This is a Validated Antibody Database (VAD) review about rat Snai1, based on 139 published articles (read how Labome selects the articles), using Snai1 antibody in all methods. It is aimed to help Labome visitors find the most suited Snai1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Snai1 synonym: Sna

Knockout validation
Cell Signaling Technology
mouse monoclonal (L70G2)
  • western blot knockout validation; human; 1:1000; fig 2
Cell Signaling Technology Snai1 antibody (Cell Signaling Tech, L7042) was used in western blot knockout validation on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (G-7)
  • western blot; human; 1:100; loading ...; fig 4d
Santa Cruz Biotechnology Snai1 antibody (SantaCruz, sc-271977) was used in western blot on human samples at 1:100 (fig 4d). Cancer Res (2021) ncbi
mouse monoclonal (G-7)
  • western blot; human; 1:1000; loading ...; fig 5c
Santa Cruz Biotechnology Snai1 antibody (Santa Cruz, sc-271977) was used in western blot on human samples at 1:1000 (fig 5c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (G-7)
  • western blot; mouse; 1:500; loading ...; fig 3b
Santa Cruz Biotechnology Snai1 antibody (Santa Cruz Biotechnology, sc-271977) was used in western blot on mouse samples at 1:500 (fig 3b). Oncogenesis (2020) ncbi
mouse monoclonal (G-7)
  • western blot; human; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology Snai1 antibody (Santa Cruz, sc-271977) was used in western blot on human samples at 1:1000 (fig 7a). Biomed Res Int (2019) ncbi
mouse monoclonal (G-7)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Snai1 antibody (Santa, sc-271977) was used in western blot on human samples (fig 5a). J Pathol (2019) ncbi
mouse monoclonal (G-7)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology Snai1 antibody (SantaCruz, sc-271977) was used in western blot on human samples (fig 3c). Mol Med Rep (2015) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s3b
Abcam Snai1 antibody (Abeam, ab180714) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 6d
Abcam Snai1 antibody (Abcam, ab180714) was used in immunohistochemistry on human samples at 1:100 (fig 6d). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; dogs; loading ...; fig 6a
Abcam Snai1 antibody (Abcam, ab180714) was used in western blot on dogs samples (fig 6a). Nature (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 9d
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Snai1 antibody (Abcam, ab180714) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 9d) and in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4b
In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Abcam Snai1 antibody (Abcam, ab180714) was used in western blot on human samples at 1:1000 (fig 4b). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Abcam Snai1 antibody (abcam, ab180714) was used in western blot on human samples (fig 3). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 6
Abcam Snai1 antibody (Abcam, ab180714) was used in western blot on rat samples (fig 6). Evid Based Complement Alternat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4
  • western blot; human; fig 4
In order to study promotion of epithelial-mesenchymal transition in human renal tubular epithelial cell via glioma-associated oncogene homolog 1, Abcam Snai1 antibody (Abcam, ab180714) was used in western blot on mouse samples (fig 4) and in western blot on human samples (fig 4). Am J Transl Res (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:75; fig 2
In order to study clear cell renal cell carcinoma and snail heterogeneity, Abcam Snai1 antibody (Abcam, ab180714) was used in immunohistochemistry - paraffin section on human samples at 1:75 (fig 2). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:100; fig 3
In order to elucidate the favor of Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma due to TAp73 loss, Abcam Snai1 antibody (Abcam, ab-180714) was used in western blot on mouse samples at 1:100 (fig 3). Cell Death Differ (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in western blot on human samples (fig 5a). Biology (Basel) (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 5a, 5c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 5a, 5c). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; rat; fig 3f
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on rat samples (fig 3f). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 6a, 6b
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, S3879) was used in western blot on human samples (fig 6a, 6b). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879S) was used in western blot on human samples (fig 4c). Oncol Lett (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples at 1:1000 (fig 4g). Front Oncol (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 4c, 4d
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 4c, 4d). Acta Pharm Sin B (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1b
Cell Signaling Technology Snai1 antibody (Cell signaling, C15D3) was used in immunohistochemistry on mouse samples at 1:500 (fig 1b). Nat Cell Biol (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 6d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3i
Cell Signaling Technology Snai1 antibody (CST, 3879s) was used in western blot on human samples at 1:1000 (fig 3i). Cancer Gene Ther (2022) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 2b). Biology (Basel) (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; loading ...; fig s10a
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on mouse samples at 1:1000 (fig s10a). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology Snai1 antibody (CST, 3879S) was used in western blot on mouse samples at 1:1000 (fig 4b). Am J Cancer Res (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 3a). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879 s) was used in western blot on human samples at 1:1000. Cell Biosci (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1f
  • immunoprecipitation; human; loading ...; fig 5i
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1f), in immunoprecipitation on human samples (fig 5i) and in western blot on human samples at 1:1000 (fig 6a). Cancer Cell Int (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6e
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6e). Oncol Rep (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 6a). Cell Prolif (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 5l, 5m
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples at 1:1000 (fig 5l, 5m). Cancer Cell Int (2020) ncbi
mouse monoclonal (L70G2)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on human samples (fig 5b). Biomed Res Int (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 2h
Cell Signaling Technology Snai1 antibody (CST, 3879S) was used in western blot on human samples at 1:1000 (fig 2h). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 2f). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology Snai1 antibody (CST, 3879S) was used in western blot on human samples at 1:1000 (fig 3d). Cancer Cell Int (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples (fig 3c). Sci Adv (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 7d
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples (fig 7d). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 2g: 2h, 2i
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples at 1:1000 (fig 2g: 2h, 2i). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; loading ...; fig 3h
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on mouse samples at 1:1000 (fig 3h). Cancer Cell (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 5a). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 3i). Mol Oncol (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • immunoprecipitation; human; 1:50; loading ...; fig 5i
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in immunoprecipitation on human samples at 1:50 (fig 5i). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; loading ...; fig 4e
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on mouse samples at 1:1000 (fig 4e). Sci Adv (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 6c
Cell Signaling Technology Snai1 antibody (CST, 3879P) was used in western blot on human samples (fig 6c). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 5a). Oncogene (2020) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 4f
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879S) was used in western blot on human samples at 1:1000 (fig 4f). Cell Death Dis (2019) ncbi
mouse monoclonal (L70G2)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Snai1 antibody (CST, 3895S) was used in western blot on human samples (fig 5a). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Snai1 antibody (CST, 3879) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; rat; 1:1000; fig 5a
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, C15D3) was used in western blot on rat samples at 1:1000 (fig 5a). Biomed Res Int (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:2000; loading ...; fig 3c
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:2000 (fig 3c). Nature (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig s2a
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig s2a). Sci Adv (2019) ncbi
mouse monoclonal (L70G2)
  • western blot; human; 1:1000; loading ...; fig 3c
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b, 4e
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on human samples at 1:1000 (fig 3c) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b, 4e). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; loading ...; fig 4e, 5f
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on mouse samples (fig 4e, 5f). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; loading ...; fig 1d
Cell Signaling Technology Snai1 antibody (cell signaling, 3879) was used in western blot on mouse samples at 1:1000 (fig 1d). Nat Cell Biol (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2a
Cell Signaling Technology Snai1 antibody (CST, C15D3) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2a). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 3a). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:500; loading ...; fig 2i
Cell Signaling Technology Snai1 antibody (Cell Signaling Technologies, 3879S) was used in western blot on human samples at 1:500 (fig 2i). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 7c, 7e
Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in western blot on human samples (fig 7c, 7e). Mol Oncol (2019) ncbi
mouse monoclonal (L70G2)
  • western blot; human; 1:1000; loading ...; fig 4a, 4b, 4c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on human samples at 1:1000 (fig 4a, 4b, 4c). Oncogene (2019) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s3c
Cell Signaling Technology Snai1 antibody (Cell signaling, C15D3) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3c). Science (2018) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 5c). Cell Death Dis (2018) ncbi
mouse monoclonal (L70G2)
  • other; human; loading ...; fig 4c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 2c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 2e
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 2e). Sci Rep (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 4a
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 4a). Mol Cancer Res (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 4c
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 4c). Oncogenesis (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 1c
In order to evaluate the regulation of Epstein-Barr virus-infected ARPE19 cell migration as a model of choroidal neovascularization, Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 1c). Exp Ther Med (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:500; loading ...; fig 4C
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879S) was used in western blot on human samples at 1:500 (fig 4C). Oncol Lett (2017) ncbi
mouse monoclonal (L70G2)
  • western blot; mouse; 1:1000; fig 5c
In order to examine whether p140Cap protein levels in ERBB2-amplified breast cancer patients correlate with survival, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on mouse samples at 1:1000 (fig 5c). Nat Commun (2017) ncbi
mouse monoclonal (L70G2)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Snai1 antibody (CST, 3895) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (L70G2)
  • western blot; human; 1:2000; loading ...; fig 7a
Cell Signaling Technology Snai1 antibody (Cell Signalling, 3,895 s) was used in western blot on human samples at 1:2000 (fig 7a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig s2
In order to evaluate the physical and functional interaction of elongation factor, RNA polymerase II, 2 with retinoblastoma in prostate cancer, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig s2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry; human; loading ...; fig 6b
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in immunohistochemistry on human samples (fig 6b) and in western blot on human samples (fig 4c). Neoplasia (2017) ncbi
mouse monoclonal (L70G2)
  • western blot; mouse; loading ...; fig 2d
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on mouse samples (fig 2d). Oncogene (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 5c). Biomed Pharmacother (2017) ncbi
mouse monoclonal (L70G2)
  • immunoprecipitation; human; loading ...; fig 1o
  • western blot; human; 1:500; loading ...; fig 1i
Cell Signaling Technology Snai1 antibody (Cell signaling, 3895) was used in immunoprecipitation on human samples (fig 1o) and in western blot on human samples at 1:500 (fig 1i). Nat Commun (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 4d
In order to find that the 'steady step' level of engulfed extracellular miRNA and its subsequent activity is dependent on the presence of a donor cell and XRN1 exonuclease, Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in western blot on human samples at 1:1000 (fig 4d). Nucleic Acids Res (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 5a
In order to determine the effects of high glucose on the epithelial-mesenchymal transition in retinal pigment epithelial cells, Cell Signaling Technology Snai1 antibody (Cell signaling, 3879S) was used in western blot on human samples (fig 5a). Int J Mol Med (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 7f
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 7f). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 3
In order to analyze the mediation of the STAT3 signaling pathway by sinomenine that inhibits A549 human lung cancer cell invasion, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 6e). Biochim Biophys Acta (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 3a). Drug Des Devel Ther (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry; mouse; loading ...; fig 8i
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in immunohistochemistry on mouse samples (fig 8i). Oncogene (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:2000; loading ...; fig 5b
In order to investigate the impact of protein arginine methyltransferase 5 in lung and breast cancer, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:2000 (fig 5b). Oncogene (2017) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 2
Cell Signaling Technology Snai1 antibody (Cell Signaling Tech, 3879) was used in western blot on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 6b
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 6b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (L70G2)
  • western blot; human; loading ...; fig 3b
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig s3b
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig s3b). Science (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; loading ...; fig 4b
In order to identify factors that contribute to the epithelial-mesenchymal transition using 16 colorectal cancer cell lines, Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in western blot on human samples (fig 4b). Cancer Sci (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 4
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (L70G2)
  • western blot; human; fig 4
In order to characterize an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications defined by PLEKHA7, Cell Signaling Technology Snai1 antibody (Cell Signaling, L70G2) was used in western blot on human samples (fig 4). Cell Cycle (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 4h
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 4h). Int J Oncol (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • immunocytochemistry; human; fig 4
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples at 1:1000 (fig 2). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 1b
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 1b). Endocr Relat Cancer (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig S5A
Cell Signaling Technology Snai1 antibody (Cell Sgnaling, 3879) was used in western blot on human samples at 1:1000 (fig S5A). Mol Oncol (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 7a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples at 1:1000 (fig 3d). Dig Dis Sci (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; fig 1
In order to investigate how reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signaling, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879S) was used in western blot on mouse samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 1
Cell Signaling Technology Snai1 antibody (Cell Signal, C15D3) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on mouse samples at 1:1000 (fig 6). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples . Mol Carcinog (2016) ncbi
mouse monoclonal (L70G2)
  • western blot knockout validation; human; 1:1000; fig 2
Cell Signaling Technology Snai1 antibody (Cell Signaling Tech, L7042) was used in western blot knockout validation on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (L70G2)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895S) was used in western blot on human samples . Neoplasia (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879S) was used in western blot on human samples at 1:1000 (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 4
Cell Signaling Technology Snai1 antibody (Cell signaling, C15D3) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (L70G2)
  • western blot; mouse; 1:1000
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, L70G2) was used in western blot on mouse samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (L70G2)
  • western blot; bovine
  • western blot; dogs
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on bovine samples and in western blot on dogs samples . Int J Mol Med (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
In order to study the relationship between nuclear LASP-1 and the epigenetic machinery in breast cancer, Cell Signaling Technology Snai1 antibody (cst, 3879P) was used in western blot on human samples . Oncogene (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; mouse; 1:1000; fig 6
In order to assess the effects of Shenling Baizhu San on colitis-associated colorectal cancer, Cell Signaling Technology Snai1 antibody (CST, C15D3) was used in western blot on mouse samples at 1:1000 (fig 6). BMC Complement Altern Med (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig s7
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig s7). Oncogene (2016) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Cell Signaling Technology Snai1 antibody (Cell Signaling Technologies, 3879) was used in western blot on human samples . Lab Invest (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; fig 3b
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples (fig 3b). Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • other; human; loading ...; fig 4c, 4f
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in other on human samples (fig 4c, 4f). PLoS ONE (2015) ncbi
mouse monoclonal (L70G2)
  • western blot; mouse
In order to demonstrate that miR-200 suppresses TGF-beta/BMP signaling, promotes epithelial gene expression, and suppresses cell invasion by regulating a network of genes, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on mouse samples . Oncogene (2016) ncbi
mouse monoclonal (L70G2)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on human samples at 1:1000 (fig 5b). Exp Ther Med (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • immunocytochemistry; human; 1:100
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 4
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 4). Cancer Lett (2015) ncbi
mouse monoclonal (L70G2)
  • chromatin immunoprecipitation; human; fig 3
Cell Signaling Technology Snai1 antibody (Cell signaling, 3895) was used in chromatin immunoprecipitation on human samples (fig 3). Ann Surg Oncol (2015) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:500
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:500. Oncotarget (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples . Cancer Cell (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human; 1:1000; fig 1a
In order to show that the zinc finger E-box binding homeobox 1 regulates radiosensitivity and the DNA damage response in breast cancer cells, Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples at 1:1000 (fig 1a). Nat Cell Biol (2014) ncbi
mouse monoclonal (L70G2)
  • chromatin immunoprecipitation; human
  • EMSA; human
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signal Technology, L70G2) was used in chromatin immunoprecipitation on human samples , in EMSA on human samples and in western blot on human samples . Biochim Biophys Acta (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3879) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L70G2)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3895) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • immunocytochemistry; human
  • western blot; human
In order to evaluate the prognostic value of fascin in pancreatic cancer, Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in immunocytochemistry on human samples and in western blot on human samples . Gastroenterology (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879) was used in western blot on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879p) was used in western blot on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the clinical significance of aldehyde dehydrogenase 1 expression in the invasive front of nasopharyngeal carcinoma, Cell Signaling Technology Snai1 antibody (Cell Signaling, C15D3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (L70G2)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on human samples . Oncol Rep (2013) ncbi
mouse monoclonal (L70G2)
  • western blot; human; 1:1000
Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
domestic rabbit monoclonal (C15D3)
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879S) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (L70G2)
  • western blot; human
In order to examine the relation of GATA3 and TGF beta in breast cancer cells, Cell Signaling Technology Snai1 antibody (Cell Signaling Technology, 3895) was used in western blot on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (C15D3)
  • ChIP-Seq; human
  • western blot; human
Cell Signaling Technology Snai1 antibody (Cell Signaling, 3879S) was used in ChIP-Seq on human samples and in western blot on human samples . J Biol Chem (2012) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
  • immunohistochemistry; mouse; loading ...; fig 2c
In order to explore the contribution of epithelial cells to systemic sclerosis pathogenesis, MilliporeSigma Snai1 antibody (Sigma, AV33314) was used in western blot on human samples (fig 1d) and in immunohistochemistry on mouse samples (fig 2c). J Exp Med (2017) ncbi
Articles Reviewed
  1. Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas J, et al. GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback. Biology (Basel). 2021;10: pubmed publisher
  2. Chen R, Sheng C, Ma R, Zhang L, Yang L, Chen Y. PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer. Mol Med Rep. 2021;24: pubmed publisher
  3. Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, et al. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Front Pharmacol. 2021;12:724141 pubmed publisher
  4. Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med. 2021;11:e522 pubmed publisher
  5. Wen J, Zhang G, Meng Y, Zhang L, Jiang M, Yu Z. RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression. Oncol Lett. 2021;22:711 pubmed publisher
  6. Yu D, Yang X, Lin J, Cao Z, Lu C, Yang Z, et al. Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer. Front Oncol. 2021;11:724655 pubmed publisher
  7. Nguyen Tran H, Nguyen T, Chen C, Hsu T. Endothelial Reprogramming Stimulated by Oncostatin M Promotes Inflammation and Tumorigenesis in VHL-Deficient Kidney Tissue. Cancer Res. 2021;81:5060-5073 pubmed publisher
  8. Zou J, Zhu X, Xiang D, Zhang Y, Li J, Su Z, et al. LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharm Sin B. 2021;11:1578-1591 pubmed publisher
  9. Scheibner K, Schirge S, Burtscher I, Büttner M, Sterr M, Yang D, et al. Epithelial cell plasticity drives endoderm formation during gastrulation. Nat Cell Biol. 2021;23:692-703 pubmed publisher
  10. Cheng X, Wang J, Liu C, Jiang T, Yang N, Liu D, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway. J Exp Clin Cancer Res. 2021;40:199 pubmed publisher
  11. Liu Q, Li H, Yang M, Mei Y, Niu T, Zhou Z, et al. Suppression of tumor growth and metastasis in Shkbp1 knockout mice. Cancer Gene Ther. 2022;29:709-721 pubmed publisher
  12. Urdiciain A, Erausquin E, Zelaya M, Zazpe I, Lanciego J, Melendez B, et al. Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines. Biology (Basel). 2021;10: pubmed publisher
  13. Wojnarowicz P, Escolano M, Huang Y, Desai B, Chin Y, Shah R, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021;7:58 pubmed publisher
  14. Xu Y, Pan S, Chen H, Qian H, Wang Z, Zhu X. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. Am J Cancer Res. 2021;11:1446-1462 pubmed
  15. Carstens J, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews K, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35:108990 pubmed publisher
  16. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  17. Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13 pubmed publisher
  18. Jiang X, Xu Y, Ren H, Jiang J, Wudu M, Wang Q, et al. KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity. Cell Biosci. 2020;10:139 pubmed publisher
  19. Huang F, Zheng C, Huang L, Lin C, Wang J. USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer. Cancer Cell Int. 2020;20:346 pubmed publisher
  20. Wang W, Wang H, Xiang L, Ni T, Jin F, Deng J, et al. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer. Oncol Rep. 2020;44:77-90 pubmed publisher
  21. Huang W, Yu D, Wang M, Han Y, Lin J, Wei D, et al. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53:e12836 pubmed publisher
  22. Lin Z, Lin X, Zhu L, Huang J, Huang Y. TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma. Cancer Cell Int. 2020;20:228 pubmed publisher
  23. Yang Y, Mei Q. Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma. Biomed Res Int. 2020;2020:1631843 pubmed publisher
  24. Qi J, Liu S, Liu W, Cai G, Liao G. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6. Aging (Albany NY). 2020;12:6904-6927 pubmed publisher
  25. Chen J, Chen S, Zhuo L, Zhu Y, Zheng H. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer. Cell Death Dis. 2020;11:173 pubmed publisher
  26. Wang X, Shan Y, Tan Q, Tan C, Zhang H, Liu J, et al. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Cancer Cell Int. 2020;20:63 pubmed publisher
  27. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed publisher
  28. Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T, et al. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis. 2020;9:26 pubmed publisher
  29. Liu K, Yu Q, Li H, Xie C, Wu Y, Ma D, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy. Am J Cancer Res. 2020;10:78-94 pubmed
  30. Li M, Wu P, Yang Z, Deng S, Ni L, Zhang Y, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10:38-59 pubmed
  31. Rinastiti P, Ikeda K, Rahardini E, Miyagawa K, Tamada N, Kuribayashi Y, et al. Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition. PLoS ONE. 2020;15:e0226049 pubmed publisher
  32. Brill Karniely Y, Dror D, Duanis Assaf T, Goldstein Y, Schwob O, Millo T, et al. Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability. Sci Adv. 2020;6:eaax2861 pubmed publisher
  33. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  34. Xu C, Zhang M, Bian L, Li Y, Yao Y, Li D. N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells. Oncogenesis. 2020;9:4 pubmed publisher
  35. Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed publisher
  36. Yu S, Zhang Y, Li Q, Zhang Z, Zhao G, Xu J. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 2019;10:949 pubmed publisher
  37. Wu Y, Chen K, Xing G, Li L, Ma B, Hu Z, et al. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Sci Adv. 2019;5:eaax7525 pubmed publisher
  38. Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H, et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis. 2019;10:918 pubmed publisher
  39. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  40. Tan P, Xu Y, Du Y, Wu L, Guo B, Huang S, et al. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death Dis. 2019;10:794 pubmed publisher
  41. Li L, Yan S, Zhang H, Zhang M, Huang G, Chen M. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. BMC Cancer. 2019;19:894 pubmed publisher
  42. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  43. Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, et al. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition. Biomed Res Int. 2019;2019:6595437 pubmed publisher
  44. Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019;571:127-131 pubmed publisher
  45. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  46. Slocum E, Craig A, Villanueva A, Germain D. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2. Breast Cancer Res. 2019;21:56 pubmed publisher
  47. Huang X, Xue H, Ma J, Zhang Y, Zhang J, Liu Y, et al. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity. J Cell Mol Med. 2019;23:4443-4453 pubmed publisher
  48. Yang H, Shen J, Wang Y, Liu Y, Shen D, Quan S. Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling. Biomed Res Int. 2019;2019:2686340 pubmed publisher
  49. Jung H, Fattet L, Tsai J, Kajimoto T, Chang Q, Newton A, et al. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Nat Cell Biol. 2019;21:359-371 pubmed publisher
  50. Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129-1151 pubmed publisher
  51. Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B, et al. F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function. J Pathol. 2019;248:266-279 pubmed publisher
  52. Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092 pubmed publisher
  53. Aggarwal S, Gabrovsek L, Langeberg L, Golkowski M, Ong S, Smith F, et al. Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility. J Biol Chem. 2019;294:3152-3168 pubmed publisher
  54. Zhang Z, Chen J, Huang W, Ning D, Liu Q, Wang C, et al. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma. Mol Oncol. 2019;13:792-810 pubmed publisher
  55. Asnaghi L, White D, Key N, Choi J, Mahale A, Alkatan H, et al. ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene. 2019;38:2056-2075 pubmed publisher
  56. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  57. Huang G, Jiang H, Lin Y, Wu Y, Cai W, Shi B, et al. lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. Cell Death Dis. 2018;9:487 pubmed publisher
  58. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  59. Palesch D, Bosinger S, Tharp G, Vanderford T, Paiardini M, Chahroudi A, et al. Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature. 2018;553:77-81 pubmed publisher
  60. Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017;8:2207 pubmed publisher
  61. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  62. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed publisher
  63. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  64. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  65. Kim D, Ko H, Park G, Hur D, Kim Y, Yang J. Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway. Exp Ther Med. 2017;13:1415-1425 pubmed publisher
  66. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed publisher
  67. Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, et al. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries. Nat Commun. 2017;8:14797 pubmed publisher
  68. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  69. Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, et al. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med. 2017;214:1129-1151 pubmed publisher
  70. Kim N, Cha Y, Lee J, Lee S, Yang J, Yun J, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017;8:14374 pubmed publisher
  71. Qiu X, Pascal L, Song Q, Zang Y, Ai J, O Malley K, et al. Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia. 2017;19:207-215 pubmed publisher
  72. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  73. He Y, Northey J, Pelletier A, Kos Z, Meunier L, Haibe Kains B, et al. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. Oncogene. 2017;36:3490-3503 pubmed publisher
  74. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  75. Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, et al. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett. 2016;12:5007-5014 pubmed publisher
  76. Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923 pubmed publisher
  77. Zangari J, Ilie M, Rouaud F, Signetti L, Ohanna M, Didier R, et al. Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition. Nucleic Acids Res. 2017;45:4131-4141 pubmed publisher
  78. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed publisher
  79. Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang Y, et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop. Oncotarget. 2016;7:63324-63337 pubmed publisher
  80. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  81. Jiang S, Gao Y, Hou W, Liu R, Qi X, Xu X, et al. Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncol Lett. 2016;12:1380-1386 pubmed
  82. Im J, Yoon S, Kim B, Ban H, Won K, Chung K, et al. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes ?-catenin-mediated invasion. Biochim Biophys Acta. 2016;1859:1449-1458 pubmed publisher
  83. Wei M, He W, Lu X, Ni L, Yang Y, Chen L, et al. JiaWeiDangGui Decoction Ameliorates Proteinuria and Kidney Injury in Adriamycin-Induced Rat by Blockade of TGF-?/Smad Signaling. Evid Based Complement Alternat Med. 2016;2016:5031890 pubmed publisher
  84. Yang S, Tsai C, Pan Y, Yeh C, Pang J, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995-2002 pubmed publisher
  85. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  86. Chen H, Lorton B, Gupta V, Shechter D. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Oncogene. 2017;36:373-386 pubmed publisher
  87. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed publisher
  88. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  89. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  90. Ding H, Xu Y, Gao D, Wang L. Glioma-associated oncogene homolog 1 promotes epithelial-mesenchymal transition in human renal tubular epithelial cell. Am J Transl Res. 2016;8:662-9 pubmed
  91. Zaldumbide L, Erramuzpe A, Guarch R, Pulido R, Cortés J, López J. Snail heterogeneity in clear cell renal cell carcinoma. BMC Cancer. 2016;16:194 pubmed publisher
  92. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed publisher
  93. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  94. Matsuda Y, Miura K, Yamane J, Shima H, Fujibuchi W, Ishida K, et al. SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer. Cancer Sci. 2016;107:619-28 pubmed publisher
  95. Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed publisher
  96. Kourtidis A, Anastasiadis P. PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications. Cell Cycle. 2016;15:498-505 pubmed publisher
  97. Yan L, Liu Y, Xiang J, Wu Q, Xu L, Luo X, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471-84 pubmed publisher
  98. Osorio L, Farfán N, Castellón E, Contreras H. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells. Mol Med Rep. 2016;13:778-86 pubmed publisher
  99. Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, et al. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer. 2016;23:147-59 pubmed publisher
  100. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed publisher
  101. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  102. Kuang X, Zhu J, Peng Z, Wang J, Chen Z. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Dig Dis Sci. 2016;61:489-500 pubmed publisher
  103. Zhao Y, Londono P, Cao Y, Sharpe E, Proenza C, O Rourke R, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun. 2015;6:8243 pubmed publisher
  104. Zhang Y, Wei X, Liang Y, Chen W, Zhang F, Bai J, et al. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. PLoS ONE. 2015;10:e0135851 pubmed publisher
  105. Mehrabian M, Brethour D, Wang H, Xi Z, Rogaeva E, Schmitt Ulms G. The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis. PLoS ONE. 2015;10:e0133741 pubmed publisher
  106. Picot N, Guerrette R, Beauregard A, Jean S, Michaud P, Harquail J, et al. Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs. Mol Carcinog. 2016;55:1150-62 pubmed publisher
  107. Haraguchi M, Sato M, Ozawa M. CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) Cells. PLoS ONE. 2015;10:e0132260 pubmed publisher
  108. Azzi S, Gallerne C, Romei C, Le Coz V, Gangemi R, Khawam K, et al. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions. Neoplasia. 2015;17:509-17 pubmed publisher
  109. Krishnan S, Szabo E, Burghardt I, Frei K, Tabatabai G, Weller M. Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition. Oncotarget. 2015;6:22480-95 pubmed
  110. Kawamura N, Nimura K, Nagano H, Yamaguchi S, Nonomura N, Kaneda Y. CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells. Oncotarget. 2015;6:22361-74 pubmed
  111. Cicchini C, de Nonno V, Battistelli C, Cozzolino A, De Santis Puzzonia M, Ciafrè S, et al. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys Acta. 2015;1849:919-29 pubmed publisher
  112. Izawa G, Kobayashi W, Haraguchi M, Sudo A, Ozawa M. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition. Int J Mol Med. 2015;36:166-72 pubmed publisher
  113. Duvall Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. 2016;35:1122-33 pubmed publisher
  114. Lin X, Xu W, Shao M, Fan Q, Wen G, Li C, et al. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration. BMC Complement Altern Med. 2015;15:126 pubmed publisher
  115. Min K, Liggett J, Silva G, Wu W, Wang R, Shen R, et al. NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway. Oncogene. 2016;35:377-88 pubmed publisher
  116. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  117. Li Y, Drabsch Y, Pujuguet P, Ren J, van Laar T, Zhang L, et al. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res. 2015;17:28 pubmed publisher
  118. Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS ONE. 2015;10:e0120192 pubmed publisher
  119. Perdigão Henriques R, Petrocca F, Altschuler G, Thomas M, Le M, Tan S, et al. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene. 2016;35:158-72 pubmed publisher
  120. Liu Y, Han X, Gao B. Knockdown of S100A11 expression suppresses ovarian cancer cell growth and invasion. Exp Ther Med. 2015;9:1460-1464 pubmed
  121. Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, et al. Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures. Int J Oncol. 2015;46:1913-23 pubmed publisher
  122. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Lett. 2015;360:269-79 pubmed publisher
  123. Hsiao S, Chen M, Chen C, Chien M, Hua K, Hsiao M, et al. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S1556-65 pubmed publisher
  124. Sun Z, Zhang C, Zou X, Jiang G, Xu Z, Li W, et al. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1. Mol Med Rep. 2015;11:3235-542 pubmed publisher
  125. Wei H, Nickoloff J, Chen W, Liu H, Lo W, Chang Y, et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget. 2014;5:9514-29 pubmed
  126. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  127. Zhang P, Wei Y, Wang L, Debeb B, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864-75 pubmed publisher
  128. Lee M, Kim S, Kim B, Won C, Nam S, Kang S, et al. Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation. Biochim Biophys Acta. 2014;1843:2037-54 pubmed publisher
  129. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  130. Xia Y, Chang T, Wang Y, Liu Y, Li W, Li M, et al. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PLoS ONE. 2014;9:e91770 pubmed publisher
  131. Li A, Morton J, Ma Y, Karim S, Zhou Y, Faller W, et al. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology. 2014;146:1386-96.e1-17 pubmed publisher
  132. D Anselmi F, Masiello M, Cucina A, Proietti S, Dinicola S, Pasqualato A, et al. Microenvironment promotes tumor cell reprogramming in human breast cancer cell lines. PLoS ONE. 2013;8:e83770 pubmed publisher
  133. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  134. Luo W, Yao K. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch. 2014;464:35-43 pubmed publisher
  135. Chen Y, Huang W, Chang S, Chang K, Kao S, Lo J, et al. Enhanced filopodium formation and stem-like phenotypes in a novel metastatic head and neck cancer cell model. Oncol Rep. 2013;30:2829-37 pubmed publisher
  136. Devine D, Rostas J, Metge B, Das S, Mulekar M, Tucker J, et al. Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-?/SMAD signaling. Oncogene. 2014;33:2620-8 pubmed publisher
  137. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, et al. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS ONE. 2013;8:e62757 pubmed publisher
  138. Chu I, Lai W, Aprelikova O, El Touny L, Kouros Mehr H, Green J. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. PLoS ONE. 2013;8:e61125 pubmed publisher
  139. Wu C, Tang S, Wang P, Lee H, Ko J. Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem. 2012;287:25292-302 pubmed publisher